AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 24/08/2009
PIL Pulmicort Turbohaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 23/07/2009 and displayed until 24/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/11/2008 and displayed until 23/07/2009
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 11/05/2005 and displayed until 05/11/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/07/2004 and displayed until 11/05/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/06/2002 and displayed until 19/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 17/06/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   budesonide